Pentetreotide - Pharm-SintezAlternative Names: Octreotide, 111In; Oktreotid, 111In
Latest Information Update: 24 Sep 2015
At a glance
- Originator Pharm-Sintez
- Class Cyclic peptides; Radiopharmaceutical diagnostics; Somatostatins
- Mechanism of Action Single-photon emission-computed tomography enhancers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Breast cancer; CNS cancer; Neuroendocrine tumours; Small cell lung cancer